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Abstract: Background: Natural language processing (NLP) is a powerful tool supporting the
generation of Real-World Evidence (RWE). There is no NLP system that enables the extensive
querying of parameters specific to multiple myeloma (MM) out of unstructured medical reports.
We therefore created a MM-specific ontology to accelerate the information extraction (IE) out of
unstructured text. Methods: Our MM ontology consists of extensive MM-specific and hierarchically
structured attributes and values. We implemented “A Rule-based Information Extraction System”
(ARIES) that uses this ontology. We evaluated ARIES on 200 randomly selected medical reports of
patients diagnosed with MM. Results: Our system achieved a high F1-Score of 0.92 on the evaluation
dataset with a precision of 0.87 and recall of 0.98. Conclusions: Our rule-based IE system enables the
comprehensive querying of medical reports. The IE accelerates the extraction of data and enables
clinicians to faster generate RWE on hematological issues. RWE helps clinicians to make decisions
in an evidence-based manner. Our tool easily accelerates the integration of research evidence into
everyday clinical practice.
Keywords: natural language processing; ontology; artificial intelligence; multiple myeloma; real
world evidence
1. Introduction
Multiple Myeloma (MM) is the third most common hematological malignancy in Germany [1].
There is still no curative MM treatment, but new drug combinations and therapy protocols are
improving overall survival. However, to investigate such new drugs it is necessary to have as much
data as possible. One source is routinely collected patient information. Unfortunately, it is a laborious
and time-consuming task to extract data from this source for Real-World Evidence (RWE) analysis.
RWE is defined as “the technology-facilitated collation of all routinely collected information on patients
from clinical systems to a comprehensive, homogeneously analyzable dataset (big data) that reflects
the treatment reality in the best possible and comparable manner” [2]. Extraction is even more difficult
in retrospective data collection, which is often based on unstructured texts like discharge letters or
medical records [3].
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Doctors at university hospitals are researchers and clinicians at the same time. Under some
circumstances, they are able to offer new drugs or new combination regimens in therapy. Some of
these may be awaiting approval by European or local regulatory authorities. But, even when patients
do not meet the criteria for inclusion in a clinical trial, clinician researchers can nevertheless offer the
therapy if, on medical request, the health insurance agrees to cover the costs. The patients then receive
up-to-date treatment.
As a consequence, scientific information is not always collected within the scope of clinical trials.
RWE is therefore of high importance. Furthermore, the results of clinical trials mirror the real world
to only a limited degree because they are highly regulated e.g., by very strictly selecting patients.
Therefore, it is essential to generate data through the RWE approach. RWE is increasingly necessary for
academic questions, (post-) approval processes and complements randomized controlled trials [2]. It is
of great interest to researchers for accelerating the process of retrieving data, especially for retrieving
data from unstructured texts [3].
This process of retrieving data can be supported by Artificial Intelligence (AI). We approached this
problem by implementing a rule-based information extraction (IE) system. This tool is specialized for
retrieving information from heterogeneously structured discharge letters and written medical reports
in the German language. The IE algorithm is able to collect not only patient characteristics but even
information that is specific to plasma cell disorders. For example, the algorithm is able to retrieve the
different stage classifications, laboratory parameters, therapy protocols, responses to therapy, adverse
reactions and comorbidities.
AI in the form of natural language processing (NLP) has several fields of application in clinical
medicine. For example, NLP accelerates the translation of cancer treatments from the laboratory to
the clinic [3]. In this regard, a crucial question is how NLP is able to generate information out of
unstructured written texts [4]. Examples of IE can be found in radiology reports [5] or transthoracic
echocardiography reports [6]. Moreover NLP finds application in oncology for case identification
and for disease stages and outcome determination [3]. NLP has been used to query clinical reports
on MM-specific parameters [7]. However, our ontology provides much more extensive querying
than these trials [7]. In addition, the extraction of information in the German language is still very
limited [8].
The aim of our IE tool is to quickly and easily enable RWE extraction for different treatments in
hematology and for further medical questions.
2. Methods
2.1. A Rule-Based Information Extraction System
We implemented ARIES, which relies on predefined ontologies to extract data from unstructured
text. ARIES is therefore an ontology-based IE system [9].
Our ontologies consist of two types of classes: attributes and values. Attributes are the main
parameters extracted from the text. Attributes include, for example, diagnoses and medications in
discharge letters or anatomical findings in radiology reports. Values, however, are more descriptive
features of attributes and therefore only exist in conjunction with an attribute. Values include,
for example locations, the severity of an attribute or the date and time at which the attribute is
measured. Since most values obviously are relevant for more than one attribute, they are organized in
groups, which we refer to as templates. Templates can be treated as multiple or single choice groups,
for example, a tumor can have multiple locations, but only one date of primary diagnosis. An attribute
can have several templates assigned.
Every attribute and value in the ontology contains extraction rules in the form of regular expressions
(regex) for finding corresponding entities in a given text. Regex are sequences of characters describing
a search pattern. Regex are used to find matching parts in the document. In addition to naive search
functions, regex implement improved functions like wildcards, repetitions of substrings and additional
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optional parts. In the first step, the text is split into segments with a configurable splitting function.
That allows the definition of a regex as a splitting point. For example, if the regex matches on periods,
an abbreviation detection mechanism is applied to prevent the system from splitting sentences too
early. In the second step, all defined attributes and values are marked for every segment. Attributes
can exist without further values, so they always get extracted. Values are discarded if they are without
at least one corresponding attribute according to the assignment in the ontology. Values that have
more than one possible match are linked to the nearest logical neighbor attribute. When the system is
trying to find single choice templates, only the longest match out of all possible values is considered.
Furthermore, every attribute can have a numerical value, for example, laboratory values. A numerical
attribute is defined by giving it a corresponding unit, for example ‘cm’ centimeters for height. If there
are different possible units, the ontology editor can define conversion factors between (e.g., “m” in
“cm”). The values of all processed instances are subsequently normalized to a uniform target unit.
If there are multiple numerical expressions in the same segment as the attribute, the nearest logical
neighbor candidate is again chosen. Figure 1 shows the architecture of the ARIES algorithm.
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Figure 1. Architecture of the ARIES algorithm. After pre-processing ARIES detects attributes, numerical
values and template values. Next, ARIES relates the detected information.
For editing the ontology, we used webATHEN (A public beta version of webATHEN is available
under http://webathen-beta.informatik.uni-wuerzburg.de/), a web clone of ATHEN [10]. This webATHEN
editor includes the ARIES algorithm. It is therefore possible to edit the ontology and execute it on
sample documents on-the-fly during its development. We used this tool because it follows a simpler
approach than, for example, Protégé [11]. So, domain experts or researchers, even if they are not
computer scientists, can operate webATHEN without extensive training periods.
ARIES is implemented in Kotlin and Java and is compatible with the UIMA Framework. Therefore,
it can easily be used in other UIMA based IE environments like cTakes [12], given an existing ontology.
2.2. Multiple Myeloma Ontology
In the MM ontology the attributes were hierarchically structured into parent and child attributes.
The parent attributes are “CRAB”, “Cytogenetic”, “Laboratory”, “Myeloma specific”, “Adverse
Events, Complications, Comorbidities”, “Response Criteria”, “Risk Factors”, “Staging”, “Therapy”
and “Substances”.
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Adding child attributes structures the ontology. For example, the attribute “Cytogenetic” has
the child attribute “High Risk Cytogenetic” which includes the following for attributes relevant to
MM: “del(17/17p)”, “t(4;14)”, “t(14;16)”, “t(14;20)” and “gain(1q)”. Supplementary Table S1 shows all
extractable attributes of our ontology. Multiple synonym expressions were added for every attribute.
This ensures the correct extraction in spite of the unstructured and free text written by different authors.
Regex were used to generalize the synonyms of an attribute and to achieve a high hit rate. For the
attribute “del(17/17p)” some synonyms are “del17p”, “17p-Deletion”, “TP.53.Deletion”, “del.*17p13.*”.
In this way, as many as possible synonyms of an attribute are included in the IE terminology,
representing the alternative spellings used in written language.
Regex were furthermore used to differentiate between attributes. For example, there are several
laboratory parameters for lambda or kappa light chains. This laboratory parameters are similar in
spelling but need to be distinguished. It is important to differentiate the parameter “kappa Leichtk”,
which measures the kappa light chains in the serum, from the parameter “kappa Leichtk. (U)”, which
measures the kappa light chains in the urine of a patient. Therefore the regex negative lookahead “kappa.
Leichtk.(?!(.*170 - 370|.*\(PU\)|.*\(U\)))” was included as a synonym of the parameter “kappa-Leichtk.”
Negative lookahead means the attribute cannot be followed by the characters in the brackets. Thus the
terminology does not read out the attribute “kappa Leichtk.” if this term is followed by “(U)”.
The ontology includes templates for the concepts “Bisphosphonate Substance”, “Date”, “Adverse
Events”, “Grade of AE”, “ICD-10”, “Light Chains”, “Light Chain Myeloma”, “Heavy Chains”,
“Protocol”, “Response”, “Therapy”, “Salmon and Durie”, “ISS” and “R-ISS”. These templates contain
several template values such as “I”, “II” and “III” for the (Revised-) International Staging System “ISS”
or “R-ISS”. In this example “ISS” is a single choice template. Therefore, the ontology will only read out
the template “III” for the attribute “III” despite of the term “III” containing “I” and “II”.
2.3. Dataset
We tested our system on the medical reports of 261 patients who met the inclusion criteria.
We included only participants who were 18 years or older, suffered from MM, received a quadruple
combination treatment and for whom data was fully available in the hospital information system.
These quadruple combinations were “VRCd” (Bortezomib, Lenalidomide, Cyclophosphamide,
Dexamethasone), Pom-PAd (Pomalidomide, Bortezomib, Doxorubicin, Dexamethasone) and PAd-Rev
(Bortezomib, Doxorubicin, Dexamethasone, Lenalidomide). The exclusion criteria were patients
younger than 18 years, patients with incomplete data sets, patients who did not give consent or
withdrew consent, or patients who did not receive any of the therapies mentioned above. For these
patients, we retrieved 5456 anonymized discharge letters in the German language from the Clinical
Data Warehouse (CDW) at the University Hospital of Würzburg in Germany, a reference center for
MM. Table 1 shows a description of our patient cohort. This cohort is representative of myeloma
cohorts described elsewhere for Germany, with 64% being male and a mean age at diagnosis of 58
years. All patients had relapsed or refractory MM (RRMM).
Table 1. Patient characteristics of our cohort.
Variable All Patients (n = 261)
Sex
Female 95
Male 166
Age at diagnosis, years (range) 58 (33–82)
Therapy
VRCd 1 74
Pom-Pad 2 123
PAd-Rev 3 64
RRMM 4 261
1 VRCd: Bortezomib, Lenalidomide, Cyclophosphamide, Dexamethasone; 2 Pom-PAd: Pomalidomide, Bortezomib,
Doxorubicin, Dexamethasone; 3 PAd-Rev: Bortezomib, Doxorubicin, Dexamethasone, Lenalidomide; 4 RRMM:
relapsed or refractory Multiple Myeloma (MM).
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For developing an initial version of the ontology, 100 randomly selected medical reports were
used as the training set. To improve the algorithm and ontology, 100 more documents were randomly
sampled and annotated with correct gold annotations as the validation set. Another 100 randomly
selected letters were also annotated with correct gold annotations but were retained as an unseen
evaluation set.
2.4. Ethical Approval
This study obtained ethical approval in 2013 from the local ethics committee of the University of
Würzburg (reference number 76/13).
3. Results
After optimizing the ontology on the training and validation set, an evaluation run was performed
on the evaluation set. The common measures in NLP—precision, recall and F1 score—were calculated
(Table 2).
Table 2. Results of the information extraction (IE) system on training and evaluation data. We counted
every attribute-value combination as well as single attribute without a value as an entity.
TP FP FN Precision Recall F1
Training 16888 2517 213 0.87 0.99 0.93
Evaluation 16077 2442 298 0.87 0.98 0.92
TP: True Positive; FP: False Positive; FN: False Negative.
Overall, the system achieved an F1-Score of 0.92 on the evaluation dataset which is slightly worse
than the result from the training dataset (0.93). This is expected because there are always unseen
cases in retained datasets. The system achieved the same precision on both evaluation and training
data (0.87). The recall of 0.98 is very high on the evaluation dataset and even higher on the training
data (0.99).
Table 3 shows the results of a few chosen attributes that are of special medical relevance. Some
parameters were very reliably extracted, whereas others were not. For example, the extraction of the
“ISS stage III” flawlessly worked (F1 1.0), while the extraction of “Light chain type kappa” suffers from
a very low precision of 0.33. All the attributes chosen had very high recall and eight out of the ten
chosen attributes had a F1-Score of 0.9 or higher.
Table 3. Detailed results for selected MM-specific parameters.
TP 1 FP 2 FN 3 Precision Recall F1
Del(17/17p) 25 0 2 1.0 0.93 0.96
ISS stage III 10 0 0 1.0 1.0 1.0
Bone marrow infiltration 206 2 8 0.99 0.96 0.98
M protein level 101 19 0 0.84 1.0 0.91
Paraprotein 106 19 0 0.85 1.0 0.98
Pathological fracture 23 0 1 1.0 0.96 0.98
Serum light chain ratio 95 14 8 0.87 0.92 0.90
Date of primary diagnosis 123 7 0 0.95 1.0 0.97
Heavy chain type IgG 111 42 0 0.73 1.0 0.84
Light chain type kappa 123 246 0 0.33 1.0 0.5
1 TP: True Positive; 2 FP: False Positive; 3 FN: False Negative.
A more detailed error analysis for the false negatives shows Table 4. In total, the IE tool produced
298 false-negative results. This number was made up of 181 values, 112 attributes and five incorrectly
extracted relations. The majority of mistakes were missing values due to a missing attribute, which
occurred 82 times. 76 out of these 82 Errors were missing synonyms of attributes but only three were
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missing synonyms of values. 20 values and 15 attributes were not retrieved because of imprecise
wording in the written medical reports. In addition, 29 values and one attribute were not extracted
because of ambiguous meanings. False-negative mistakes were less common due to spelling errors in
the written medical reports. These spelling errors occurred 17 times with attributes and six times with
values. A minor role played errors regarding the single check option, the segmentation or wrong or
missing units.
Table 4. Results of the detailed error analysis.
Type of Mistake Missing Value Missing Attribute Wrong Relation
Missing synonym 3 76
Ambiguous meaning 29 1
Missing value due to missing attribute 82 0
Imprecise wording 20 15
Single check option 8 0
Spelling error 6 17
Segmentation error 12 0
Wrong unit 11 0
Not assignable 10 3
Total 181 112 5
4. Discussion
Written medical reports such as discharge letters or tumor conference protocols are a way of
communication in everyday clinical practice [3]. These reports are used by treating doctors of different
departments or are sent to the general practitioners (GPs) of patients in order to update the GPs on the
medical history and condition of shared patients. In addition, these reports record information for
subsequent consultation. Thus, written medical reports present a large amount of clinical real world
data which is available for retrospective research [2]. It is however a laborious and time-consuming task
to tap into this valuable RWE information. One reason is that only a small part of any medical report
is structured [3]. Reports often change in structure over time or because they have different authors.
Unstructured and imprecise written medical reports are also often produced because physicians have
little time and high workloads. While some report passages are written in a staccato-like noun phrase
style, they also contain lots of written unstructured text. This relevant data in the report is less accessible
and more difficult to filter out. As a result, a lot of information is lost in incoherent reports.
Acquiring RWE is of utmost importance today [2,3,13]. It takes on a strong complementary
position to randomized controlled trials (RCT) with their limitations. RCTs are still the gold standard of
research but they are limited in their generalizability and applicability to everyday clinical practice [13].
Only 3–5% of cancer patients receive treatment as part of an RCT [13,14]. For example, RCT are
conducted on patients that are much younger and have fewer comorbidities than the average oncological
patient [14,15]. Moreover, RCTs are high in cost and expenses, whereas RWE can tap into already
existing and available clinical data.
While therapeutic options and the demand for individual medicine increase, there is a need for a
tool that improves oncological evidence-based research and quality [3]. NLP can accelerate the process
of translating cancer treatment from bench to bedside or from academic centers to being a reality of
everyday treatment. NLP also supports generating RWE. RWE helps clinicians to make decisions in an
evidenced-based manner. Thus, NLP helps in integrating research into everyday clinical practice [3].
First, NLP can harvest valuable information which would otherwise be lost in free text medical reports.
Second, NLP saves resources and accelerates the querying of medical reports and the retrieval of
information [3].
Our objective was therefore to support the process of retrieving this data out of retrospective
clinical written reports in the German language. The emphasis was hereby on extracting clinical and
research relevant information on patients diagnosed with MM. Our tool queries a vast amount of
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MM related attributes, as shown in Supplementary Table S1. It is constructed to extract the baseline
characteristics such as specific laboratory parameters or staging classifications. Furthermore, it is
trained to capture the different treatments and therapy protocols, the responses to them, and the
adverse events or relapses that occur. However, the extraction is not limited to this. It is able to retrieve
comprehensive data on each individual history. Examples are patient risk factors or comorbidities. Our
ontology can easily be extended by attributes, expanding its range of query even further. Our current
system is only able to query reports written in German. However, some attributes are the same in
English, whereas others can be easily translated and added.
The ontology created is particularly appropriate for supporting retrospective studies of MM
protocols in regard to overall response (ORR), progression free survival (PFS) and overall survival
(OS). We are in the process of using our terminology to perform a study on the effectiveness, ORR, PFS
and OS of myeloma patients who received a quadruple therapy.
NLP has a wide range of application in research and everyday clinical practice. It is of use for
example in radiology reports [5] or transthoracic echocardiography reports [6]. In oncology NLP is
used for identifying disease stages [16], and evaluating outcomes (such as adverse drug reactions [17]
or tumor recurrences [18]). Other NLP projects targeting MM take into account performance to identify
genes associated with MM [19], “a standardized hierarchic ontology of cancer treatments” [20] or an
“ontology-driven semiological rules base and a consultation form to aid in the diagnosis of plasma
cells diseases” [21].
Nevertheless, we only found one case in which NLP was utilized to retrieve patient data from
unstructured free text on MM. Löpprich, Krauss et al. [7] created a “multiclass classification of free-text
diagnostic reports” and “a framework to enable automatic multi-class classification of relevant data
elements from free-text diagnostic reports”. Their aim was to automatically document “diagnosis and
state of disease of myeloma patients” from clinical reports. They trained two different classifiers—a
support vector machine (SVM) and a maximum entropy classifier (MEC)—on a self-created dataset
and obtained F1 scores: 0.92 for SVM, 0.89 for MEC, similar or slightly inferior to ours. However, their
range of parameters was limited and their data source was only a small part of the whole document
(the main diagnosis paragraph). Our tool thus exceeds theirs in the range of myeloma-specific and
additional data queried.
One possible limitation of our system is that it has a lower precision than recall. Our precision in
the evaluation was 0.87, while the recall amounted to 0.98. We developed our system in a way, that
attributes were correctly identified and were only extracted if identified in the right context. There
were a lot of false positives from attributes that were correctly extracted but not found in the right
context. For example, every discharge letter has an introduction instructing the GP to contact the clinic
“if the patient has fever over 37.5 degree Celsius”. The algorithm correctly finds the attribute “fever”
and relates it to the value “37.5” and unit “Degrees Celsius”, but this is not the right context because it
is just a recommendation and not a real status. If a researcher is looking for patients suffering from
“fever” in a CDW or cancer registry, he would find this patient mistakenly. Another example is the
extraction of “light chain type kappa”, which suffers from a low precision (Table 3). This low precision
arises from our very strict evaluation. We considered the data to be correctly annotated only if it was
extracted in the right context. Since “kappa” is frequently used and is also a component of multiple
parameters of our MM ontology, we received a high number of false positives. These redundantly
extracted attributes and values are easily understood as “not relevant” by a person manually working
in a medical field. But automatic data mining struggles with such text. Nevertheless, several of the
attributes chosen (Table 3) reached a high precision and F1-Score. Especially successfully extracted
were “ISS Stage III”, “Bone marrow infiltration”, “Paraprotein” and “Pathological fracture” and this
shows the strength and reliability of our tool.
Our error analysis (Table 4) shows that the majority of mistakes were missing values due to
missing attributes. Most of these values were not detected because the corresponding attribute was
not in the same segment. For example, if the value “VCD”, a therapy protocol abbreviation, stands in
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one segment without its attribute “Cycle”, it won’t be retrieved. We can solve this problem by adding
these values as attributes. The second most frequent error was missing synonyms. These were often
associated with a corresponding value and so were not detected either. Missing synonyms of values
however were not so much of a problem. Other common errors were values and attributes that were
not retrieved due to imprecise wording in the written medical reports. One example is an author
who insufficiently describes the Salmon and Durie Staging System. In these cases, reports mentioned
the stage without details. In addition, values and one attribute with an ambiguous meaning were
not extracted. This problem particularly occurred with abbreviations. One example is the response
criterion “stable disease”, which is abbreviated as “SD”. However, “SD” is ambiguous because it is
also an abbreviation for the German word for thyroid gland: “Schilddrüse”.
Another possible limitation is the patient cohort on which we trained the ontology. We didn’t
have a detailed look at these patients. We randomly picked medical reports of patients, meeting our
inclusion and exclusion criteria. There can be a selection bias regarding this inclusion and exclusion
criteria. We will address the details of several patient cohorts with ARIES in future research.
Our ontology-based tool can be used as a data extraction tool for multiple purposes. This tool is
integrated into the CDW of the University Hospital of Würzburg [22]. Extracted data can be combined
with other facts from structured data like ICD-10 or OPS codes. The CDW can be used for further
integrity checks. One example is the post-processing of “ISS” and “R-ISS” stage, which can be checked
for reliance. It is not logically possible to have the stage “ISS” with value “I” together with “R-ISS”
value “III”. Such an occurrence indicates an error in the report or the extraction. Several criteria have
to be fulfilled for the “R-ISS” stage “III”, including “ISS” stage “III” and “above upper limit lactate
dehydrogenase in laboratory” or “one high risk marker present in cytogenetic”.
Moreover, our ontology is implemented in the cancer registry of lower Franconia, a part of the
cancer registry in Bavaria. CDWs and cancer registries contain big data and bring together a great deal
of important information in one place. Big data analysis and results should be integrated into research
and clinical practice. Access to big data is of great relevance for cancer research and will help clinicians
evaluate outcomes, make evidence-based decisions and promote personalized medicine, especially in
academic centers where many uncommon therapies are applied [3,23–25].
Because the data extracted for the cancer registry will be corrected later on, we are planning to
use our system to build a larger gold dataset for the above defined attributes. With a larger dataset,
we will reproduce, or even outperform, the results with a deep learning approach or other machine
learning algorithms, such as neural networks.
5. Conclusions
We demonstrate the creation of the first comprehensive rule-based IE system able to query
unstructured written medical reports in MM. While our tool has slightly lower precision than recall,
the redundantly extracted information is recognized as irrelevant by medical professionals. Our system
is better than existing ones in extracting MM-specific information. It is designed to query German
medical reports, however it is easily possible to add translations into English or other languages.
The main focus was to address plasma cell disorder issues, thus helping to generate RWE. RWE
helps clinicians to decide in an evidence-based manner and integrates research into everyday clinical
practice. We developed an IE system which enables and accelerates the extraction of valuable patient
information. This will allow us to generate big data for clinical trials, cancer registries, and for future
machine learning approaches.
Supplementary Materials: The following are available online at http://www.mdpi.com/2077-0383/8/7/999/s1,
Table S1: Attributes Covered by Multiple Myeloma Ontology.
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